June 12, 2025- Thermo Fisher Scientific Inc., will showcase its latest innovative and flexible solutions designed to maximize efficiency and scale manufacturing in support of biotechnology and biopharmaceutical companies at every stage of their drug development journey during the 2025 BIO International Convention, June 16-19 (booth #2953). Thermo Fisher will also showcase recently launched innovations that deliver increased flexibility, enhanced performance and the ability to optimize complex workflows for customers.
Leaders from across the organization will also participate in a series of panel discussions highlighting industry trends, strategies for sustainability and the value of collaboration to bring medicines to market faster.
Key industry partnerships help drive the breadth of Thermo Fisher’s latest platforms, solutions and services that accelerate drug development. These collaborations enable the company to support its customers advancing therapy manufacturing across a number of indications and modalities, including cell and exosome therapy, mental health disorders and advanced formulations for therapeutics and vaccines.
Company subject matter experts will be available at the booth to discuss new platforms designed to accelerate therapeutics development, including the CHO K-1 cell line, which has been shown to reduce timelines to Investigational New Drug (IND) filing from 13 to nine months.